Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Analysis of survey data looking at 25 years of progress in and the future challenges for tropical medicine and global health
Vaccine Management in Indonesia
Resources for the Prevention and Treatment of Substance Use Disorders (SUD)
Frequently asked questions on Antimicrobial resistance.
Perspectivas sobre las drogas
Moving towards equity and quality
Perspectives sur les drogues
This block contains a wide variety of disorders that differ in severity (from uncomplicated intoxication and harmful use to obvious psychotic disorders and dementia), but that are all attributable to the use of one or more psychoactive substances (which may or may not have been medically prescribed)
First edition, November 1997 | Revised July 2002
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.